Detection of anti-Mycobacterium avium subspecies paratuberculosis antibodies in thyroid and type-1 diabetes patients by Chaubey, Kundan Kumar et al.
Indian Journal of Biotechnology 







Detection of anti-Mycobacterium avium subspecies paratuberculosis antibodies in 
thyroid and type-1 diabetes patients  
Kundan Kumar Chaubey
1
, Shoor Vir Singh
1*













, Krishna Dutta Rawat
2
 
1Department of Biotechnology, Institute of Applied Sciences and Humanities, GLA University, Mathura, Uttar Pradesh- 281406, India 
2Department of Bio-Nanotechnology, Guru Jambheshwar University, Hisar-125001, India  
Received 18 September 2018; revised 22 June 2019; accepted 10 September, 2019 
Mycobacterium avium subspecies paratuberculosis (MAP) causes granulomatous intestinal disease in animals (Johne’s 
diseases). MAP has also been associated with several autoimmune disorders. In this study, we screened serum samples from 
confirmed patients of thyroid and type 1 diabetes for the presence of antibody against MAP. We used newly developed 
'cocktail ELISA' (based on recombinant secretary proteins) and extensively validated 'indigenous ELISA' (based on whole 
cell protoplasmic antigen) and both the tests were also compared for their diagnostic potential. A total of 90 serums samples 
were included of which anti-MAP antibodies was detected in 28.8% and 26.6% of samples by indigenous ELISA (iELISA) 
and cocktail ELISA (cELISA), respectively. There was almost perfect agreement between the two tests in detecting the  
anti-MAP antibodies. Study raises concern on high detection of anti-MAP antibodies in human, thus warranting necessary 
control measure to minimize MAP exposure in human beings.  
Keywords: Mycobacterium avium subspecies paratuberculosis, type 1 diabetes, thyroid, cocktail & indigenous ELISA.  
Introduction 
Mycobacterium avium subspecies paratuberculosis 
(MAP), the causative agent of Johne’s disease (JD) in 
domestic livestock species, has wide host range. MAP 
infection has been reported in wild animal species, 
primates and also in humans
1-2
. MAP has been 
strongly associated with Crohn’s disease (CD) in 
humans due to similar pathology, isolation of  
MAP isolate and other supportive evidences
3
. In 
addition to CD, MAP has also been implicated in 
multiple diseases like type 1 diabetes, Hashimoto’s 





Early and accurate diagnosis is key element in 
control of JD, however due to absence of dedicated 
control programme in India and variable sensitivity 
and specificity of available diagnostics it remains 
difficult to restrict the transmission of MAP.  
enzyme linked immunosorbent assay (ELISA) is one 
of the most frequently used screening tests used for 
the detection of MAP infection, however, variable 
sensitivity and specificity of available commercial 
diagnostics is an important issue. Earlier, we have 
developed indigenous ELISA  
(iELISA) using whole cell protoplasmic antigen 
from native strain of MAP‘S 5’ Indian bison type. 
Although, iELISA showed superior diagnostic value 
as compared to commercial ELISA
5
, still there is a 
scope of further improving the sensitivity and 
specificity of test. 
Secreted antigens have long been acknowledged to 
play central roles in bacterial-host interactions and it 
can serve as markers for early diagnosis of disease
6
. 
Previous study demonstrated increased sero-reactivity 
of secretary proteins as compared to other cellular 
proteins in MAP-infected animals
7
. Thus, use of 
secretary antigens may increase the sensitivity of 
ELISA substantially for sub-clinically infected cattle. 
Recently we developed new cocktail ELISA  
(cELISA) test by using six sero-reactive secretary 
proteins (1693c, 2168c, ModD, 85C, Pep AN and Pep 
AC). In our previous studies, cELISA was found 
sensitive to detect the MAP infection and also had 
potential to differentiate between infected and 
vaccinated animals (DIVA)
8
. Here, we aim to 
compare the diagnostic potential of both cELISA 
against iELISA in detecting anti-MAP antibodies in 
patients suffering from thyroid and type 1 diabetes. 
—————— 
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Materials and Methods 
 
Ethics 
This study was undertaken as part of a multi-
centric project (outreach project on zoonotic diseases) 
granted by Indian Council of Medical Research 
(ICMR), New Delhi. The study was approved by 
Ethical Committee of National JALMA Institute, 
Agra (a collaborating institute for the same project). 
 
Sample and ELISA Testing  
A total of 90 blood samples from confirmed cases 
of thyroid and type-1 diabetes patients were included 
in this study. Serum from blood samples was 
harvested and stored at -20
o
C until tested by ELISA. 
Each samples were tested using cELISA and iELISA 
as per method described earlier
8-9
. We used known 
positive (showing high titer for anti-MAP antibodies) 
and negative human sera as control for calculating 
and interpreting the test result. 
 
Test Result Interpretation and Statistical Analysis 
Optical densities (OD) of samples were 
transformed and expressed as sample-to-positive (S/P) 
ratios
10
. Based on calculated S/P ratio, samples were 
categorized as negative (N; 0.00-0.09), suspected  
(S; 0.1-0.24), low positive (LP; 0.25-0.39), positive 
(P; 0.4-0.99) and strong positive (SP; 1.0-10.0). To 
achieve meaningful statistical outcome and also in 
view of high mycobacterial exposure among 
population (due to BCG vaccination, high TB burden 
and frequent presence of mycobacteria in 
environment), samples with high S/P ratio were only 
considered as ‘positive’. Therefore, samples with S/P 
ratio ≥ 0.40 (P+SP) were considered as ‘positive’ and 
samples with S/P ratio 0.00-0.39 (N+S+LP) were 
considered as ‘negative’. 
Considering iELISA as standard method, percent 
sensitivity of cELISA was determined. Additionally, 
proportional agreement and statistical difference 
between the two tests were also analyzed using kappa 
statistics and McNemar's calculation, respectively 
(GraphPad software, USA).   
 
Results 
Our study showed the presence of anti-MAP 
antibody among patients with thyroid/diabetes. Of 
total 90 samples tested, 26 (28.8%) and 24 (26.7%) 
samples were detected as positive by iELISA and 
cELISA, respectively. As compared to cELISA, 
iELISA detected 2 additional samples as positive. 
However, profiling in context to S/P ratio was better 
in cELISA. Of the 24 samples falling in category of 
positive (P) by iELISA, 7 were grouped into strong 
positive (SP) by cELISA. Similarly, samples 
classified under low positive (LP), suspected (S) and 
negative (N) by iELISA were differentially classified 
by cELISA. Samples stratified into different 
categories of S/P ratio by both the ELISA tests are 




Fig. 1 — S/P ratio based profiling of samples tested by iELISA 
and cELISA using scattered plot analysis. (Abbreviation:  
S/P- sample to positive; P- positive; N- negative)  
 
 
Table 1 — Sero-status of patients (n = 90) tested for anti-MAP antibodies using iELISA and cELISA 
iELISA 
n (%) 
cELISA n (%) 
Positive; 24 (26.7)  Negative; 66 (73.3) 
SP P LP S N 
7 (7.8) 17 (18.9) 7 (7.8) 16 (17.8) 43 (47.8) 
Positive 
26 (28.9) 
SP 0 (0.0) - - - - - 
P 26 (28.8) 7 17 2 - - 
Negative 
64 (71.1) 
LP 10 (11.1) - - 4 3 3 
S 23 (25.5) - - 1 8 14 
N 31 (34.4) - - - 5 26 
LP- low positive; S- suspected; N- negative; P- positive; SP- strong positive  
 




Proportional agreement between both the tests to 
detect anti-MAP antibodies was 97.8% (kappa score= 
0.945; CI=0.869 to 1.000), thus showing a perfect 
agreement. The analytical difference between the two 
ELISA tests was non-significant (p=0.7392). 
 
Discussion 
MAP is endemic among domestic livestock in 
India.  Since MAP is excreted through milk of 
infected animals, it is therefore continuously entering 
into human food chain. In recent past, sufficient 
evidence has been obtained to clearly show that many 
patients with auto-immune disorders, especially 
Crohn’s disease are infected with MAP
11
. MAP has 
also been implicated in type 1 diabetes as a putative 
environmental agent triggering or accelerating the 
disease and also in Hashimoto's thyroiditis which is a 
common cause of hypothyroidism
12
. Our study 
reported high presence of anti-MAP antibodies among 
patients suffering from either thyroid disorder or type 
1 diabetes. In agreement with our observation, high 
presence of anti-MAP antibodies has also been 
reported earlier in Iranian diabetes patients
13
. Our 
study has limitation as we could not collect patient 
history/demographics due to limited accesses with 
patients.    
MAP is a major threat for both livestock and 
human population in this century. Using semi-purified 
protoplasmic antigen of goat origin harvested from 
'Indian bison type' biotype of MAP (strain 'S5’) based 
‘iELISA’ showed significantly higher sensitivity as 
compared to commercially available ELISA kits
14-18
. 
Indigenous ELISA correlated well with culture and 
performed as good screening test for domestic 
livestock
19 
and human population as well
20
. In our 
earlier study, we evaluated the diagnostic efficacy of 
iELISA in culture positive CD patients. All culture 
positive CD cases showed positive sero-status in 
iELISA, thus indicating iELISA as sensitive and 
accurate to detect MAP infection
20
. In present study, 
our newly developed cELISA also showed  
sensitivity close to iELISA. On analyzing the data as 
per different categories of S/P ratio, it is observed that 
out of 43 samples classified by cELISA as negative, 
14 were borderline and 3 were in low positive 
category. Thus, indicating more sensitive or have 
better profiling of infection stage by cELISA. As 
another limitation of study, the precise sensitivity and 
specificity of test could not be assessed due to non-
inclusion of any gold standard test. Culture, though 
considered as gold standard test but its sensitivity and 
specificity also get compromised due to progressive 
nature of disease (which involves different 
immunological mechanism in early, sub-clinical and 
clinical stages) and intermittent shedding of bacteria 
in clinical samples (feces and milk). Moreover, 
culture has disadvantage in term of long turn-around 
time (about 2-3 months) to get the result. Therefore, 
immunological test like ELISA seems as promising 
screening tool for MAP infection. 
Although not investigated, cELISA may have 
higher specificity than iELISA since only few 
selected antigenic proteins was used that obviously 
minimize the cross-reactivity. This assumption is well 
supported by our previous study in which cELISA 
showed differentially high titer among infected 
animals as compared titer detected among vaccinated 
animals. Considering this important differential 
diagnostic value and high sensitivity in detecting anti-
MAP antibodies in animal and humans, cELISA 
deserve to be further evaluated and explored for 
future control program. 
 
Conclusions 
This study demonstrated utility of ELISA test in 
screening of MAP infection. Both, whole cell 
protoplasmic and secretary antigens had similar 
diagnostic potential in detecting anti-MAP antibodies. 
High presence of anti-MAP antibodies warrant further 
investigation on the role of MAP in precipitation and 
progression of thyroiditis and type 1 diabetes. 
Furthermore, necessary action needs to be taken to 
minimize the exposure of MAP to human beings.  
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